REPISALUD es el REPositorio Institucional de SALUD del Instituto de Salud Carlos III (ISCIII) y sus Fundaciones, el
Centro Nacional de Investigaciones Cardiovasculares (CNIC) y el Centro Nacional de Investigaciones Oncológicas (CNIO),
en el que se recoge en un único archivo digital y de acceso libre, la producción científica y académica de estos centros
de referencia en sus áreas.
Informes y estudios institucionales del ISCIII sobre COVID-19
Añadido Recientemente
Living with chronic illness scale in Parkinson's disease: Longitudinal metric properties and meaningful change
Aim: To analyze the responsiveness and interpretability of the Living with Chronic Illness Scale in patients with Parkinson’s disease (LW-CI-PD). Methods: Longitudinal, international study, with a convenience sample of 153 PD Spanish and Latin-American patients assessed at baseline and one year lat...
Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection
LGMDD2 is a rare form of muscular dystrophy characterized by one of the three heterozygous deletions described within the TNPO3 gene that result in the addition of a 15-amino acid tail in the C-terminus.TNPO3 is involved in the nuclear import of splicing factors and acts as a host cofactor for HIV-...
Assessing the effect of non-pharmaceutical interventions on COVID-19 transmission in Spain, 30 August 2020 to 31 January 2021
Background: After a national lockdown during the first wave of the COVID-19 pandemic in Spain, regional governments implemented different non-pharmaceutical interventions (NPIs) during the second wave. Aim: To analyse which implemented NPIs significantly impacted effective reproduction number (Rt) ...